Business
First Healthy Adult Subject Dosed in Phase 1 Trial of ARG007
First Healthy Adult Subject Dosed in Phase 1 Trial of ARG007
About this update from Argenica Therapeutics Ltd
[{"type":"text","content":"Argenica Therapeutics Ltd has released a press release. View Attachment","length":255,"tagName":"div"}]